SCHEMBL15039580

SCHEMBL15039580

O=C1C=C(Nc2ccc(O)c(Cl)c2)/C(=N\c2ccc(O)c(Cl)c2)C=C1Nc1ccc(O)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.42
▸ GSK3B P49841 6/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ STK10 O94804 3/20 0.38
▸ SLK Q9H2G2 3/20 0.38
▸ GSK3A P49840 3/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ BRDT Q58F21 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HSD17B3 P37058 1/20 0.33
▸ HSD17B2 P37059 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ CCNB2 O95067 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CDK1 P06493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020065 1.00 DNM1 (0.42) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15020067 1.00 DNM1 (0.42) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15039543 0.94 DNM1 (0.40) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15039793 0.93 DNM1 (0.40) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL16426675 0.91 DNM1 (0.38) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15020486 0.91 DNM1 (0.38) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15020488 0.91 DNM1 (0.38) DNM1GSK3BPTGS1PTGS2STK10
SCHEMBL15039585 0.88 MAPK14 (0.41) DNM1GSK3BSTK10SLKGSK3A
SCHEMBL15039790 0.86 DNM1 (0.49) DNM1GSK3BPTGS1PTGS2ALDH1A1
SCHEMBL15039789 0.81 DNM1 (0.35) DNM1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 DNM1 2808/4885GSK3B 2678/4885PTGS1 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback